Realistic Evaluation of Expériences Animées, a School-based Intervention in Nouvelle Aquitaine (ERIEAS)
11 octobre 2022 mis à jour par: University Hospital, Bordeaux
The study is a realistic evaluation of the Expériences Animées school-based programme.
The aim is to precisely characterize i) the effects in terms of alcohol and cannabis consumption, the use of health professionals in case of problematic use of those two substances; ii) the context and underpinning mechanisms triggered by the program in terms of changes of alcohol and cannabis representations and life skills development.
This evaluation could allow to produce the key functions of the programme: how the intervention works, in which conditions.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
- Alcohol consumption represents the second main modifiable risk factor for cancer and the second preventable mortality cause in France, after tobacco use. It is mainly during adolescence, which corresponds to a period of integration with peers and a period of detachment from parents, that alcohol use starts. In France, alcohol remains the substance that adolescents most experiment with. A 2014 report shows that nearly half (49.4%) of first-year secondary school pupils have already tried an alcoholic drink and about one in seven secondary school pupils' reports having been drunk. The impact of cannabis consumption is wide as it can affect the social environment, the brain and the psychology of the consumers. Adolescence is a period during which the brain undergoes profound remodelling in areas that are high in cannabinoid receptors and that mediate cognitive control and emotion regulation. Therefore, childhood and adolescence are important stages of life on which preventive efforts may be focused, also because events occurring in the earliest stages of human development (before birth and during childhood) are known to be related to further risk for cancer, other chronic diseases and adult conditions.
- Among addiction prevention programmes, those that focus on life skills have been mentioned in the literature as being effective. In this context, the French organization "Association Ressources et Initiatives Addictions" (ARIA) has developed Expériences Animées programme (animated experiences) based on the above features, with the aim to help adolescents to change their representations and strengthen their life skills. This is a grassroots innovation. It has to be evaluated.
- The Expériences Animées programme involves supervised short movies and talks with secondary and high school pupils about the use of psychoactive substances. The movies are made specifically for the programme. The sessions are facilitated by two professionals including at least a clinical psychologist. In a given secondary/high school, one session per term is delivered for each class (40 classes). Three to five films are shown at each session. Each film aims to work on 2 to 3 life skills allowing to build protective behaviors against addictions. This programme is implemented since 2015.
- The investigators will collect quantitative and qualitative data to appraise the outcomes (O), mechanisms (M) and contextual elements (C), including the interventional elements) in order to verify the initial theories (hypothesis of causal pathways) by i) Questionnaires to collect outcomes in terms of consumption and health care, and some mechanisms: 2/ Non-directive interviews to collect mechanisms and contextual factors 3/ Observations to collect contextual elements during the sessions. The investigators will design the survey instruments in line with the initial middle-range theories identified.
Type d'étude
Observationnel
Inscription (Réel)
1026
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
-
Bordeaux, France, 33000
- CIC1401-EC - CHU de Bordeaux Centre Inserm U1219
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
Méthode d'échantillonnage
Échantillon non probabiliste
Population étudiée
Pupils from 10 secondary and hugh schools in the department of Charente (France)
La description
Inclusion Criteria:
Pupils :
- Pupils from the 10 secondary and high schools selected in the department of Charente, in 2nd and 5th years in 2019/2020 academic year,
- Pupils not opposite to participate and holders of parental authority not opposite to the participation of the child (no later than the day of inclusion)
Others :
- Non-opposition to participate of 3 Education professionals per establishment in the 10 secondary and high schools selected in the department of Charente,
- Non-opposition to participate of 2 session leaders,
- Non-opposition to participate of 3 funders.
Exclusion Criteria:
- Participants under legal protection
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: Autre
- Perspectives temporelles: Éventuel
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Expériences Animées Programme
The Expériences Animées programme involves supervised short movies and talks with secondary school and high school pupils about the use of psychoactive substances.
|
The questionnaires are completed at the 3 survey times (T0, T1 and T2) by all pupils involved.
Collected data are quantitative
The interviews are conducted with 80 pupils/year randomly selected (i.e. 2 per class and 8 per establishment/year).
Collected data are qualitative
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Daily, alcohol consumption
Délai: 3 years
|
Alcohol consumption per day at study entry, after 1 year and after 2 years
|
3 years
|
|
Weekly, alcohol consumption
Délai: 3 years
|
Alcohol consumption per week at study entry, after 1 year and after 2 years
|
3 years
|
|
Monthly, alcohol consumption
Délai: 3 years
|
Alcohol consumption per month at study entry, after 1 year and after 2 years
|
3 years
|
|
Number of episodes of heavy drinking
Délai: 3 years
|
An episode of heavy drinking : at least 5 drinks per occasion at study entry, after 1 year and after 2 years
|
3 years
|
|
Number of drunkenness episodes
Délai: 3 years
|
Number of episodes at study entry, after 1 year and after 2 years
|
3 years
|
|
Weekly, cannabis consumption
Délai: 3 years
|
Number of cannabis consumption per week at study entry, after 1 year and after 2 years
|
3 years
|
|
Monthly, cannabis consumption
Délai: 3 years
|
Number of cannabis consumption per month at study entry, after 1 year and after 2 years
|
3 years
|
|
Yearly, cannabis consumption
Délai: 3 years
|
Number of cannabis consumption per year at study entry, after 1 year and after 2 years
|
3 years
|
|
Number of consultation of a healthcare professional to discuss about a problematic use of alcohol and/or cannabis
Délai: 3 years
|
Number of times at study entry, after 1 year and after 2 years
|
3 years
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: François ALLA, MD PhD, CIC1401-EC, Inserm-CHU de Bordeaux
Publications et liens utiles
La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
30 septembre 2019
Achèvement primaire (Réel)
16 juin 2022
Achèvement de l'étude (Réel)
16 juin 2022
Dates d'inscription aux études
Première soumission
26 septembre 2019
Première soumission répondant aux critères de contrôle qualité
27 septembre 2019
Première publication (Réel)
1 octobre 2019
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
12 octobre 2022
Dernière mise à jour soumise répondant aux critères de contrôle qualité
11 octobre 2022
Dernière vérification
1 octobre 2022
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- CHUBX 2018/75
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .